Dafna Capital Management LLC Genocea Biosciences, Inc. Transaction History

Dafna Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$1.81 - $5.53 $949,641 - $2.9 Million	-524,664 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$1.66 - $3.06 $29,714 - $54,774	-17,900 Reduced 3.3%	524,664 $1.21 Million
Q3 2019 Nov 14, 2019	SELL	$2.9 - $4.07 $556,388 - $780,862	-191,858 Reduced 26.12%	542,564 $1.57 Million
Q2 2019 Aug 14, 2019	BUY	$3.47 - $6.71 $2.55 Million - $4.93 Million	734,422 New	734,422 $2.88 Million

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Dafna Capital Management LLC with notifications on news.